HOME >> MEDICINE >> NEWS
Specific test key to determine whether or not allergy symptoms are really allergy-related

COLUMBUS, Ohio Many people with allergy-like symptoms could get the test they need, and the right treatments for their symptoms, from their primary care physician if managed care practice guidelines encouraged the use of the test.

The savings nationally might equal the costs of an additional doctor's visit to a specialist for more than 20 million Americans. A typical charge for an office visit to an allergy specialist is around $100, about twice the cost of a visit to a family doctor.

A new study suggests that family physicians could better serve their patients with symptoms related to hay fever, or allergic rhinitis, by using a definitive blood test to screen for actual allergies. The test can easily be administered in a physician's office, and the test results are easy to interpret.

Instead of testing for allergies, most family physicians are likely to prescribe medications or suggest that their patients use over-the-counter drugs to help control suspected allergy symptoms, said Sheryl Szeinbach, the study's lead author and a professor of pharmacy practice and administration at Ohio State University. And most people with allergy symptoms first seek help from their family doctor.

With hay fever season nearly upon us, anywhere from 20 to 50 million Americans will develop allergic rhinitis. Symptoms include red and watery eyes, irritated nasal passages, a runny nose and sneezing and coughing. Having a definitive diagnosis is key to treatment, Szeinbach said.

"Family physicians need to use a blood test that specifically tests for the allergens that trigger allergic rhinitis," she said, adding that some doctors already use blood testing. "Knowing whether or not allergy-like symptoms are actually caused by an allergy is key for determining the appropriate course of treatment."

Szeinbach is referring to a blood test that evaluates the reaction of Immunoglobulin E (IgE) to specific allergens, such as pollen from grass and t
'"/>

Contact: Sheryl Szeinbach
zbach@dendrite.pharmacy.ohio-state.edu
614-688-4249
Ohio State University
22-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. Now Is Time To Design Brain-Saving Drugs Specifically For Children, UCSF Neurologist Says
2. Study determines commonly used contrast agent safe for universal use in CT
3. MDCT angiography can potentially help determine which patients are at greater risk of stroke
4. PITT, OHSU: When early life stress occurs determines its impact later
5. UCSD researchers determine fatty liver disease different in obese children than in adults
6. Researchers invent way to determine optimal conditions for spinal cord nerve regen in lab animals
7. Combination PET/CT should be used to determine stage of non-small cell lung cancer
8. UCSD researchers determine fibrin depletion decreases multiple sclerosis symptoms
9. Northwestern Memorial launches trial to determine most effective treatment for hepatitis C
10. Hawaii community focus groups determine priorities for oral health research
11. Risk factors determine need for colonoscopy

Post Your Comments:
(Date:5/22/2013)... 22, 2013 Cedars-Sinai Heart Institute is honoring ... pioneer in modern mitral heart valve repair, Alain ... Corday, MD, International Prize in Heart Research. The ... recognize physicians and scientists conducting groundbreaking research, or ... medicine. , Carpentier is a leading ...
(Date:5/22/2013)... A new study provides neurobiological evidence for ... in people with insomnia, which may have implications ... , "Insomnia has been consistently identified as a ... Franzen, PhD, an assistant professor of psychiatry at ... in the brain circuitry underlying emotion regulation may ...
(Date:5/22/2013)... May 22, 2013 Digital Advertising Agency, ... behalf of its social media management client, Primal ... year's supply of the all-natural organic deodorant. The contest ... of the rapidly-growing start-up deodorant company based in Tampa, ... contest or sweepstakes on a Facebook page is a ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 DiscountFurnaceFilter.com ... quality merchandise ranging from furnace filters, dehumidifiers, fans, ... is excited to add Stadler Form's product line ... summer product line (fans, aroma diffusers and dehumidifiers) ... Form’s Otto Fan is the perfect combination of ...
(Date:5/22/2013)... York, NY and Troy, NY (PRWEB) May 22, ... Medicine at Mount Sinai and Rensselaer Polytechnic Institute ... educational programs, research, and development of new diagnostic ... alliance was commemorated in a signing ceremony on ... initiative to use their expertise—Rensselaer’s in engineering and ...
Breaking Medicine News(10 mins):Health News:Heart valve repair innovator receives Cedars-Sinai Heart Institute's Corday Prize in Heart Research 2Health News:Study shows that insomnia may cause dysfunction in emotional brain circuitry 2Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7
(Date:5/22/2013)... TORONTO , May 22, 2013 /PRNewswire/ ... announced three presentations demonstrating the superiority of the AE37 ... Antigen Express, Inc. ( www.antigenexpress.com ). The presentations will ... Society of Clinical Oncology (ASCO) to be held in ... June 4, 2013. The presentation entitled " ...
(Date:5/22/2013)... -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary ... announced on May 22 the actions that Ranbaxy ... conduct under prior management ( ... to support Ranbaxy in its efforts to address ... led to the investigations by the U.S. Department ...
(Date:5/22/2013)... 22. Mai 2013  Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4
Cached News: